Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells

Nature Immunology

Volumn 9, Issue 11, 2008, Pages 1244-1252

  Young, Louise J ^a   Wilson, Nicholas S ^a,b,e,f,g   Schnorrer, Petra ^a,e,f,g   Proietto, Anna ^a   ten Broeke, Toine ^c   Matsuki, Yohei ^d   Mount, Adele M ^a   Belz, Gabrielle T ^a,b   O'Keeffe, Meredith ^a,e,f,g   Ohmura Hoshino, Mari ^d   Ishido, Satoshi ^d   Stoorvogel, Willem ^c   Heath, William R ^a,b   Shortman, Ken ^a   Villadangos, Jose A ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Department of Civil and Environmental Engineering   (Australia)

^c UTRECHT UNIVERSITY   (Netherlands)

^d RIKEN Center for Integrative Medical Sciences   (Japan)

^e GENENTECH INC   (United States)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g Bavarian Nordic GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; PROTEIN MARCH1; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME ANALYSIS; INFLUENZA VIRUS; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; T LYMPHOCYTE ACTIVATION; UBIQUITINATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD11; ANTIGENS, CD45; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 54549091964     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1665     Document Type: Article

References (45)

1. Villadangos, J.A., Schnorrer, P. & Wilson, N.S. Control of MHC class II antigen presentation in dendritic cells: A balance between creative and destructive forces. Immunol. Rev. 207, 191-205 (2005).
2. Shortman, K. & Naik, S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7, 19-30 (2007).
3. Villadangos, J.A. & Schnorrer, P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7, 543-555 (2007).
4. Ohmura-Hoshino, M. et al. Inhibition of MHC class II expression and immune responses by c-MIR. J. Immunol. 177, 341-354 (2006).
5. Shin, J.S. et al. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444, 115-118 (2006).
6. van Niel, G. et al. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 25 885-894 (2006).
7. Matsuki, Y. et al. Novel regulation of MHC class II function in B cells. EMBO J. 26, 846-854 (2007).
8. De Gassart, A. et al. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc. Natl. Acad. Sci. USA 105, 3491-3496 (2008).
9. Thibodeau, J. et al. Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur. J. Immunol. 38, 1225-1230 (2008).
10. Ohmura-Hoshino, M. et al. A novel family of membrane-bound E3 ubiquitin ligases. J. Biochem. 140, 147-154 (2006).
11. Romani, N. et al. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169, 1169-1178 (1989).
12. Young, L.J. et al. Dendritic cell preactivation impairs MHC class II presentation of vaccines and endogenous viral antigens. Proc. Natl. Acad. Sci. USA 104, 17753-17758 (2007).
13. Colonna, M., Trinchieri, G. & Liu, Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219-1226 (2004).
14. Liu, Y.J. IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23 275-306 (2005).
15. Ehst, B.D., Ingulli, E. & Jenkins, M.K. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am. J. Transplant. 3, 1355-1362 (2003).
16. O'Keeffe, M. et al. Distinct roles for the NF-κB1 and c-Rel transcription factors in the differentiation and survival of plasmacytoid and conventional dendritic cells activated by TLR-9 signals. Blood 106, 3457-3464 (2005).
17. Delamarre, L., Pack, M., Chang, H., Mellman, I. & Trombetta, E.S., Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307, 1630-1634 (2005).
18. LeibundGut-Landmann, S., Waldburger, J.M., Reis e Sousa, C., Acha-Orbea, H. & Reith, W. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat. Immunol. 5 899-908 (2004).
19. Germain, R.N. & Hendrix, L.R. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353, 134-139 (1991).
20. El-Sukkari, D. et al. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J. Immunol. 171, 5003-5011 (2003).
21. ilson, N.S., El-Sukkari, D. & Villadangos, J.A. Dendritic cells constitutively present self antigens in their immature state in vivo, and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103, 2187-2195 (2004).
22. Dadaglio, G., Nelson, C.A., Deck, M.B., Petzold, S.J. & Unanue, E.R. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6, 727-738 (1997).
23. + T cells: A new role for plasmacytoid dendritic cells in adaptive immunity. Blood 101, 3520-3526 (2003).
24. De Heer, H.J. et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200, 89-98 (2004).
25. Salio, M., Palmowski, M.J., Atzberger, A., Hermans, I.F. & Cerundolo, V. CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J. Exp. Med. 199, 567-579 (2004).
26. Schnurr, M. et al. Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery. Blood 105, 2465-2472 (2005).
27. Ochando, J.C. et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7 652-662 (2006).
28. Zhang, J. et al. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 107, 3600-3608 (2006).
29. +, T cells by plasmacytoid dendritic cells. J. Exp. Med. 204, 1923-1933 (2007).
30. Meyer-Wentrup, F. et al. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production. Blood 111, 4245-4253 (2008).
31. Wilson, N.S. et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7, 165-172 (2006).
32. + T-cell response. Nat. Rev. Immunol. 4, 595-602 (2004).
33. Janssen, E.M. et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434 88-93 (2005).
34. - but not plasmacytoid dendritic cells. J. Exp. Med. 205, 1621-1634 (2008).
35. Barnden, M.J., Allison, J., Heath, W.R. & Carbone, F.R. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76, 34-40 (1998).
36. Scott, B. et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1, 73-83 (1994).
37. + T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157, 978-983 (1996).
38. Ogilvy, S. et al. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc. Natl. Acad. Sci. USA 96, 14943-14948 (1999).
39. Wilson, N.S. et al. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102, 2187-2194 (2003).
40. Vremec, D., Pooley, J., Hochrein, H., Wu, L. & Shortman, K. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164, 2978-2986 (2000).
41. O'Keeffe, M. et al. Mouse plasmacytoid cells: Long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8+ dendritic cells only after microbial stimulus. J. Exp. Med. 196, 1307-1319 (2002).
42. - dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174, 6592-6597 (2005).
43. Alfonso, C., Han, J.O., Williams, G.S. & Karlsson, L. The impact of H2-DM on humoral immune responses. J. Immunol. 167, 6348-6355 (2001).
44. Villadangos, J.A., Riese, R.J., Peters, C., Chapman, H.A. & Ploegh, H.L. Degradation of mouse invariant chain: Roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J. Exp. Med. 186, 549-560 (1997).
45. Barois, N., Forquet, F. & Davoust, J. Selective modulation of the major histocompatibility complex class II antigen presentation pathway following B cell receptor ligation and protein kinase C activation. J. Biol. Chem. 272, 3641-3647 (1997).